Health X Platform Executes Tripartite Agreement for Subsidiary Merger

Health X Platform Limited (formerly Sastasundar Ventures Limited) approved a Tripartite Agreement with material subsidiary Sastasundar Healthbuddy Limited (SHBL) and Envision India Fund for SHBL's merger into the company.

Agreement Background

The agreement follows Envision's Share Purchase Agreement dated February 25, 2026, acquiring Mitsubishi Corporation's entire SHBL shareholding. Post-transaction SHBL shareholding: Health X (17,100,160 eq. shares), Rohto Pharmaceuticals (3,562,064 eq. shares), Envision (10,13,766 eq. shares).

Merger Structure and Contingencies

The Tripartite Agreement outlines a scheme of arrangement merging SHBL into Health X, preserving Envision's economic interest equivalent to its pre-merger SHBL stake, subject to legal compliance. If merger fails, Health X commits to share swap ensuring Envision receives equivalent Health X shares for SHBL holdings.

Envision gains board nomination rights upon material breach or merger non-consummation.

Shares of Sastasundar Ventures Limited was last trading in BSE at Rs. 282.20 as compared to the previous close of Rs. 280.35. The total number of shares traded during the day was 39 in over 19 trades.

The stock hit an intraday high of Rs. 288.95 and intraday low of 282.00. The net turnover during the day was Rs. 11121.00.

Source : Equity Bulls

Keywords

HealthXPlatform INE019J01013 HealthcareServices Merger